Anita L Ray
Overview
Explore the profile of Anita L Ray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ray A, Saunders A, Nofchissey R, Reidy M, Kamal M, Lerner M, et al.
Clin Cancer Res
. 2023 Mar;
29(11):2158-2169.
PMID: 36951682
Purpose: G-CSF enhances colon cancer development. This study defines the prevalence and effects of increased G-CSF signaling in human colon cancers and investigates G-CSF inhibition as an immunotherapeutic strategy against...
2.
Geddes A, Ray A, Nofchissey R, Esmaeili A, Saunders A, Bender D, et al.
Front Oncol
. 2022 Nov;
12:986103.
PMID: 36387163
Women with colorectal cancer (CRC) have survival advantages over men, yet the underlying mechanisms are unclear. T cell infiltration within the CRC tumor microenvironment (TME) correlates strongly with survival. We...
3.
Saunders A, Bender D, Ray A, Wu X, Morris K
PLoS One
. 2021 Feb;
16(2):e0247233.
PMID: 33606788
Colorectal cancer is the 2nd leading cause of cancer-related deaths in the world. The mechanisms underlying CRC development, progression, and resistance to treatment are complex and not fully understood. The...
4.
Ray A, Nofchissey R, Khan M, Reidy M, Lerner M, Wu X, et al.
Br J Cancer
. 2020 May;
123(4):624-632.
PMID: 32451467
Background: Women with colorectal cancer (CRC) have a significant survival advantage over men. Sex influences on the tumour microenvironment (TME) are not well characterised, despite the importance of immune response...
5.
Phinney B, Ray A, Peretti A, Jerman S, Grim C, Pinchuk I, et al.
Front Immunol
. 2018 Oct;
9:1857.
PMID: 30298062
A major risk factor for colon cancer growth and progression is chronic inflammation. We have shown that the MAPK-activated protein kinase 2 (MK2) pathway is critical for colon tumor growth...
6.
Ray A, Berggren K, Cruz S, Gan G, Beswick E
Int J Cancer
. 2017 Dec;
142(8):1702-1711.
PMID: 29197088
Colorectal cancer (CRC) development and progression is associated with chronic inflammation. We have identified the MAPK-activated protein kinase 2 (MK2) pathway as a primary mediator of inflammation in CRC. MK2...
7.
Castillo E, Ray A, Beswick E
Macrophage (Houst)
. 2016 Mar;
3.
PMID: 26998523
Colorectal cancer (CRC) is one of the most common malignancies and is associated closely with inflammation before and after development. Macrophages promote colitis and colitis-associated CRC. M1 macrophages contribute to...
8.
Ray A, Castillo E, Morris K, Nofchissey R, Weston L, Samedi V, et al.
Int J Cancer
. 2015 Aug;
138(3):770-5.
PMID: 26238259
Chronic inflammation is a risk factor for colorectal cancer. The MAPK-activated protein kinase 2 (MK2) pathway controls multiple cellular processes including p38-dependent inflammation. This is the first study to investigate...
9.
Morris K, Castillo E, Ray A, Weston L, Nofchissey R, Hanson J, et al.
Oncotarget
. 2015 Jun;
6(26):22338-47.
PMID: 26061815
Granulocyte colony-stimulating factor (G-CSF) is a cytokine that is highly expressed in human and mouse colorectal cancers (CRC). We previously reported that G-CSF stimulated human CRC cell growth and migration,...